Literature DB >> 500826

Ethylmalonic-adipic aciduria. In vivo and in vitro studies indicating deficiency of activities of multiple acyl-CoA dehydrogenases.

S Mantagos, M Genel, K Tanaka.   

Abstract

The mechanisms underlying ethylmalonic-adipic aciduria were studied in a 5-yr-old girl. Oxidation of radioactive substrates by cultured skin fibroblasts from the proband and asymptomatic family members was also determined and compared to that by normal fibroblasts and that by cells from a patient with glutaric aciduria type II. Feeding medium-chain triglycerides promptly induced vomiting and lethargy accompanied by a pronounced increase of urinary ethylmalonate. Significant increases of serum isovalerate and urinary isovalerylglycine were observed after leucine feeding, but urinary glutarate increased only slightly after lysine feeding. Thus, the results from clinical investigation remained equivocal as to whether pathways other than fatty acid oxidation were blocked in our patient. Oxidation of [1-(14)C]butyrate by cultured skin fibroblasts from the proband was reduced to 14% of control. In vitro oxidation of [2-(14)C]lysine and [2-(14)C]leucine was also reduced to 28 and 23% of control, respectively. Much more severe reduction in oxidation of these three substrates (3, 9, and 9%, respectively) was observed in glutaric aciduria type II cells. These results indicated that in the proband, degradative pathways of fatty acids, lysine, and leucine are blocked at the steps of butyryl-CoA, glutaryl-CoA, and isovaleryl-CoA dehydrogenases, respectively, as in the case of glutaric aciduria type II. Because activities of multiple acyl-CoA dehydrogenases are reduced, a deficiency of electron-transferring flavoprotein, which serves as a hydrogen-acceptor for these dehydrogenases, is postulated as the underlying mechanisms of these two diseases, but a genetic heterogeneity was indicated by significant differences in the residual activities in these two types of cells. The hypothesis of more than one mutant allele of an autosomal recessive gene was also suggested by the study on cells from asymptomatic members of the family.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 500826      PMCID: PMC371311          DOI: 10.1172/JCI109619

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  ENZYMOLOGICAL DETERMINATION OF FREE CARNITINE CONCENTRATIONS IN RAT TISSUES.

Authors:  N R MARQUIS; I B FRITZ
Journal:  J Lipid Res       Date:  1964-04       Impact factor: 5.922

2.  Studies on omega-oxidation of fatty acids in vitro. I. Overall reaction and intermediate.

Authors:  K WAKABAYASHI; N SHIMAZONO
Journal:  Biochim Biophys Acta       Date:  1963-04-23

3.  Specificity of carnitine action on fatty acid oxidation by heart muscle.

Authors:  I B FRITZ; E KAPLAN; K T YUE
Journal:  Am J Physiol       Date:  1962-01

4.  Identification of n-hexanoylglycine in urines from two patients with Jamaican vomiting sickness.

Authors:  B H Baretz; H S Ramsdell; K Tanaka
Journal:  Clin Chim Acta       Date:  1976-11-15       Impact factor: 3.786

5.  Investigation of the mechanism of the methylmalonyl-CoA mutase reaction with the substrate analogue: ethylmalonyl-CoA.

Authors:  J Rétey; E H Smith; B Zagalak
Journal:  Eur J Biochem       Date:  1978-02

6.  New defect in fatty-acid metabolism with hypoglycemia and organic aciduria.

Authors:  K Tanaka; S Mantagos; M Genel; M R Seashore; B A Billings; B H Baretz
Journal:  Lancet       Date:  1977-11-05       Impact factor: 79.321

7.  Metabolism in rats in vivo of RS-2-methylbutyrate and n-butyrate labeled with stable isotopes at various positions. Mechanism of biosynthesis and degradation of ethylmalonyl semialdehyde and ethylmalonic acid.

Authors:  B H Baretz; C P Lollo; K Tanaka
Journal:  J Biol Chem       Date:  1979-05-10       Impact factor: 5.157

8.  The isolation and identification of N-isovalerylglycine from urine of patients with isovaleric acidemia.

Authors:  K Tanaka; K J Isselbacher
Journal:  J Biol Chem       Date:  1967-06-25       Impact factor: 5.157

9.  Demonstration of a new mammalian isoleucine catabolic pathway yielding an Rseries of metabolites.

Authors:  O A Mamer; S S Tjoa; C R Scriver; G A Klassen
Journal:  Biochem J       Date:  1976-12-15       Impact factor: 3.857

10.  On the mode of action of hypoglycin A. 3. Isolation and identification of cis-4-decene-1,10-dioic, cis, cis-4,7-decadiene-1,10-dioic, cis-4-octene-1,8-dioic, glutaric, and adipic acids, N-(methylenecyclopropyl)acetylglycine, and N-isovalerylglycine from urine of hypoglycin A-treated rats.

Authors:  K Tanaka
Journal:  J Biol Chem       Date:  1972-12-10       Impact factor: 5.157

View more
  26 in total

1.  Multiple sources of metabolic disturbance in ETHE1-related ethylmalonic encephalopathy.

Authors:  Magalie Barth; Chris Ottolenghi; Laurence Hubert; Dominique Chrétien; Valérie Serre; Stéphanie Gobin; Stéphane Romano; Anne Vassault; Aziz Sefiani; Daniel Ricquier; Nathalie Boddaert; Michèle Brivet; Yves de Keyzer; Arnold Munnich; Marinus Duran; Daniel Rabier; Vassili Valayannopoulos; Pascale de Lonlay
Journal:  J Inherit Metab Dis       Date:  2010-10-27       Impact factor: 4.982

Review 2.  Biochemical relationships between Reye's and Reye's-like metabolic and toxicological syndromes.

Authors:  J Osterloh; W Cunningham; A Dixon; D Combest
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Jul-Aug

3.  Multiple acyl-CoA dehydrogenase deficiency: a neonatal onset case responsive to treatment.

Authors:  Z H Verjee; W G Sherwood
Journal:  J Inherit Metab Dis       Date:  1985       Impact factor: 4.982

4.  The diagnosis and biochemical investigation of a patient with a short chain fatty acid oxidation defect.

Authors:  M J Bennett; R G Gray; D M Isherwood; N Murphy; R J Pollitt
Journal:  J Inherit Metab Dis       Date:  1985       Impact factor: 4.982

5.  Biosynthesis of electron transfer flavoprotein in a cell-free system and in cultured human fibroblasts. Defect in the alpha subunit synthesis is a primary lesion in glutaric aciduria type II.

Authors:  Y Ikeda; S M Keese; K Tanaka
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

6.  Complementation analysis of fatty acid oxidation disorders.

Authors:  A Moon; W J Rhead
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

7.  Glutaric acidaemia type II (multiple acyl-CoA dehydrogenation deficiency).

Authors:  S I Goodman; F E Frerman
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

8.  Neonatal glutaric aciduria type II: an X-linked recessive inherited disorder.

Authors:  F X Coude; H Ogier; C Charpentier; G Thomassin; A Checoury; O Amedee-Manesme; J M Saudubray; J Frezal
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

9.  Prenatal diagnosis of glutaric aciduria type II by direct chemical analysis of dicarboxylic acids in amniotic fluid.

Authors:  C Jakobs; L Sweetman; S K Wadman; M Duran; J M Saudubray; W L Nyhan
Journal:  Eur J Pediatr       Date:  1984-01       Impact factor: 3.183

10.  Complementation studies of isovaleric acidemia and glutaric aciduria type II using cultured skin fibroblasts.

Authors:  B Dubiel; C Dabrowski; R Wetts; K Tanaka
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.